BL1332
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BL1332, covering 2026-01-27 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy [Phase 2]